BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28780353)

  • 1. Ultra-microsecond pulsed curcumin for effective treatment of triple negative breast cancers.
    Mittal L; Raman V; Camarillo IG; Sundararajan R
    Biochem Biophys Res Commun; 2017 Sep; 491(4):1015-1020. PubMed ID: 28780353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective electrochemotherapy with curcumin in MDA-MB-231-human, triple negative breast cancer cells: A global proteomics study.
    Mittal L; Aryal UK; Camarillo IG; Raman V; Sundararajan R
    Bioelectrochemistry; 2020 Feb; 131():107350. PubMed ID: 31518962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo.
    Hsieh MT; Chang LC; Hung HY; Lin HY; Shih MH; Tsai CH; Kuo SC; Lee KH
    Eur J Med Chem; 2017 May; 131():141-151. PubMed ID: 28319780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
    Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
    Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLGA-CTAB curcumin nanoparticles: Fabrication, characterization and molecular basis of anticancer activity in triple negative breast cancer cell lines (MDA-MB-231 cells).
    Meena R; Kumar S; Kumar R; Gaharwar US; Rajamani P
    Biomed Pharmacother; 2017 Oct; 94():944-954. PubMed ID: 28810532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput, Label-Free Quantitative Proteomic Studies of the Anticancer Effects of Electrical Pulses with Turmeric Silver Nanoparticles: an in vitro Model Study.
    Mittal L; Camarillo IG; Varadarajan GS; Srinivasan H; Aryal UK; Sundararajan R
    Sci Rep; 2020 Apr; 10(1):7258. PubMed ID: 32350346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendrosomal nanocurcumin and exogenous p53 can act synergistically to elicit anticancer effects on breast cancer cells.
    Baghi N; Bakhshinejad B; Keshavarz R; Babashah S; Sadeghizadeh M
    Gene; 2018 Sep; 670():55-62. PubMed ID: 29753810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic anticancer action of quercetin and curcumin against triple-negative breast cancer cell lines.
    Kundur S; Prayag A; Selvakumar P; Nguyen H; McKee L; Cruz C; Srinivasan A; Shoyele S; Lakshmikuttyamma A
    J Cell Physiol; 2019 Jul; 234(7):11103-11118. PubMed ID: 30478904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).
    Godugu C; Doddapaneni R; Singh M
    Colloids Surf B Biointerfaces; 2017 May; 153():208-219. PubMed ID: 28249200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125.
    Seitz S; Buchholz S; Schally AV; Weber F; Klinkhammer-Schalke M; Inwald EC; Perez R; Rick FG; Szalontay L; Hohla F; Segerer S; Kwok CW; Ortmann O; Engel JB
    BMC Cancer; 2014 Nov; 14():847. PubMed ID: 25410881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptotic Resistance of Metastatic Tumor Cells in Triple Negative Breast Cancer: Roles of Death Receptor-5.
    Kamalabadi-Farahani M; H Najafabadi MR; Jabbarpour Z
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1743-1748. PubMed ID: 31244295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping Novel Metabolic Nodes Targeted by Anti-Cancer Drugs that Impair Triple-Negative Breast Cancer Pathogenicity.
    Roberts LS; Yan P; Bateman LA; Nomura DK
    ACS Chem Biol; 2017 Apr; 12(4):1133-1140. PubMed ID: 28248089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-Ferritin Enriches the Curcumin Uptake and Improves the Therapeutic Efficacy in Triple Negative Breast Cancer Cells.
    Pandolfi L; Bellini M; Vanna R; Morasso C; Zago A; Carcano S; Avvakumova S; Bertolini JA; Rizzuto MA; Colombo M; Prosperi D
    Biomacromolecules; 2017 Oct; 18(10):3318-3330. PubMed ID: 28886247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Antiproliferation Potency of Electrical Pulse-Mediated Metformin and Cisplatin Combination Therapy on MDA-MB-231 Cells.
    Sahu P; Camarillo IG; Sundararajan R
    Appl Biochem Biotechnol; 2022 Jan; 194(1):18-36. PubMed ID: 34741262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDA-MB-231 cells.
    Eldehna WM; El-Naggar DH; Hamed AR; Ibrahim HS; Ghabbour HA; Abdel-Aziz HA
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):309-318. PubMed ID: 29281924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and structure-activity relationship studies of a focused library of pyrimidine moiety with anti-proliferative and anti-metastasis activities in triple negative breast cancer.
    Yao D; Zhou Y; Zhu L; Ouyang L; Zhang J; Jiang Y; Zhao Y; Sun D; Yang S; Yu Y; Wang J
    Eur J Med Chem; 2017 Nov; 140():155-171. PubMed ID: 28923383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin sensitizes carboplatin treatment in triple negative breast cancer through reactive oxygen species induced DNA repair pathway.
    Wang G; Duan P; Wei Z; Liu F
    Mol Biol Rep; 2022 Apr; 49(4):3259-3270. PubMed ID: 35076853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative proteomic analysis of enhanced cellular effects of electrochemotherapy with Cisplatin in triple-negative breast cancer cells.
    Mittal L; Aryal UK; Camarillo IG; Ferreira RM; Sundararajan R
    Sci Rep; 2019 Sep; 9(1):13916. PubMed ID: 31558821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced targeting of triple-negative breast carcinoma and malignant melanoma by photochemical internalization of CSPG4-targeting immunotoxins.
    Eng MS; Kaur J; Prasmickaite L; Engesæter BØ; Weyergang A; Skarpen E; Berg K; Rosenblum MG; Mælandsmo GM; Høgset A; Ferrone S; Selbo PK
    Photochem Photobiol Sci; 2018 May; 17(5):539-551. PubMed ID: 29565434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.